ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Tools
Markets
Discover
Subscribe Login/Register Profile Icon
S&P TSX Capped Composite...
32.47
(
0.28%
)
US Tech 100
15,700.80
(
0.54%
)
S&P 500
4,604.37
(
0.41%
)
US Dollar vs CAD
1.35945
(
0.0%
)
Bitcoin
44,034.63
(
-0.34%
)
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Vertex Pharmaceuticals Inc (VRTX)

  7. Vertex Pharmaceuticals Inc (VRTX) News

VRTX Vertex Pharmaceuticals Inc

350.15
-3.80 (-1.07%)
Dec 08 2023 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Vertex Pharmaceuticals Inc VRTX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-3.80 -1.07% 350.15 18:44:09
Open Price Low Price High Price Close Price Previous Close
354.00 348.46 354.35 350.15 353.95
more quote information »

Recent News

Date Time Source Heading
12/08/202315:11DJNBluebird Bio Shares Slide 41% on Black-Box Label, Higher..
12/08/202311:59EDGAR2Form 8-K - Current report
12/08/202311:52BWVertex and CRISPR Therapeutics Announce US FDA Approval of..
12/08/202310:46DJNCRISPR, Vertex Get FDA OK of Casgevy Gene Therapy in..
12/06/202315:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/06/202315:03EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/05/202315:14EDGAR2Form 8-K - Current report
12/05/202315:01BWVertex Appoints Nancy Thornberry to its Board of Directors
11/29/202313:55DJNVertex Pharmaceuticals' Kalydeco Gets Expanded Use..
11/29/202313:00PRNCASanté Canada autorise la mise sur le marché de KALYDECO(MD)..
11/29/202312:59PRNCAHealth Canada Grants Market Authorization for KALYDECO®..
11/24/202309:06DJNVertex Pharmaceuticals Gets Regulatory OK to Extend Use to..
11/24/202308:13BWVertex Announces European Medicines Agency Validation for..
11/23/202308:54DJNVertex Pharmaceuticals Cystic Fibrosis Treatment Approved..
11/23/202308:05BWEuropean Commission Approves KAFTRIO® in Combination With..
11/21/202315:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/20/202310:54EDGAR2Form 144 - Report of proposed sale of securities
11/17/202315:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/17/202315:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/16/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/16/202300:45BW Vertex and CRISPR Therapeutics Announce Authorization of..
11/15/202315:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/15/202313:32DJNVertex Pharmaceuticals Worst Performer in the S&P 500 and..
11/15/202309:29EDGAR2Form 144 - Report of proposed sale of securities
11/15/202309:26EDGAR2Form 144 - Report of proposed sale of securities
11/14/202310:59EDGAR2Form 144 - Report of proposed sale of securities
11/13/202314:51EDGAR2Form 144 - Report of proposed sale of securities
11/08/202315:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/07/202315:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/202306:10IHMARKETNEWSTuesday’s Wall Street Highlights: WeWork, UBS, Sanofi,..
11/06/202315:46DJNVertex Pharmaceuticals 3Q Profit Rises on Continued Sales..
11/06/202315:05EDGAR2Form 8-K - Current report
11/06/202315:01BWVertex Reports Third Quarter 2023 Financial Results
11/06/202310:50EDGAR2Form 144 - Report of proposed sale of securities
11/02/202315:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/02/202308:02BWVertex to Present New Data on Exagamglogene Autotemcel..
11/02/202307:30BWVertex to Present Data Highlighting Long-Term Benefits of..
11/01/202305:29DJNCrispr Therapeutics Shares Rally Premarket After Favorable..
10/31/202310:33EDGAR2Form 144 - Report of proposed sale of securities
10/26/202307:00BWVertex to Present at Upcoming Investor Conferences
10/19/202315:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/19/202315:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/18/202315:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/17/202315:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/17/202315:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/17/202314:30DJNVertex Pharmaceuticals Gets Health Canada Label Expansion..
10/17/202313:45PRNCASanté Canada autorise la commercialisation de TRIKAFTA(MD)..
10/17/202313:44PRNCAHealth Canada Grants Market Authorization for TRIKAFTA®..
10/17/202310:00EDGAR2Form 144 - Report of proposed sale of securities
10/17/202309:53EDGAR2Form 144 - Report of proposed sale of securities

Your Recent History

NASDAQ
VRTX
Vertex Pharmaceuticals
Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com